Rare diseases
Investigational molecules
Locations
Study of Mosunetuzumab Treatment in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis
ItalyStudy of BGB-16673 in combination with drug therapy for patients with relapsed or refractory B-cell malignancies
GermanyStudy Comparing Mosunetuzumab and Lenalidomide with Other Treatments for Patients with Relapsed or Refractory Marginal Zone Lymphoma
BelgiumStudy on Mosunetuzumab and Lenalidomide for Untreated Follicular Lymphoma Patients
BelgiumStudy of Mosunetuzumab and Zanubrutinib for Patients with Relapsed or Refractory Follicular Lymphoma
ItalyStudy of Mosunetuzumab and Polatuzumab Vedotin for Patients with Diffuse Large B-Cell Lymphoma After Initial Treatment or in Elderly/Unfit Untreated Patients
PolandStudy of Mosunetuzumab and Drug Combination for Untreated Patients with Richter's Syndrome
SpainStudy on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma
AustriaStudy on the Safety and Effects of Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma
FranceStudy on the Safety and Effectiveness of Mosunetuzumab and Atezolizumab for Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
GermanyStudy of Mosunetuzumab and Polatuzumab Vedotin Combination Treatment in Patients with B-Cell Non-Hodgkin Lymphoma
BelgiumStudy of Mosunetuzumab for Patients with Early Relapse of Follicular Lymphoma
DenmarkTell us about your condition – we search every trial in Europe and connect you with the right site.
